APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Peptides

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Selected research

Industry Research

Antimicrobial Peptides Industry Research Report 2026

1 January 2026129 pages

Choose your research edition.

Industry ResearchAntimicrobial Peptides Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Peptides Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Antimicrobial Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Peptides Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Peptides Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

Read the full market overview

Report Scope

This report quantifies the global Antimicrobial Peptides market in terms of revenue (US$ million) and, where applicable, sales volume (Mg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Mg) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antimicrobial Peptides Market by Company

AnaSpec

AMP Biotech

Phoenix Biotech

Novabiotics

Chinese Peptide

Ontores

GenScript

Hycult Biotech

Sunsmile

Ruixing Biotechnology

Zhongnong Yingtai Biotechnology

Glam Technology

ProteLight Pharmaceutical & Biotechnology

Antimicrobial Peptides Segment by Type

Plant Antimicrobial Peptides

Microbial Antimicrobial Peptides

Animal Antimicrobial Peptides

Antimicrobial Peptides Segment by Application

Pharmaceuticals

Feed Additives

Others

Antimicrobial Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antimicrobial Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antimicrobial Peptides Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antimicrobial Peptides Sales (Mg) of Manufacturers (2021-2026) Table 7. Global Antimicrobial Peptides Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antimicrobial Peptides Revenue of Manufacturers (2021-2026) Table 9. Global Antimicrobial Peptides Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antimicrobial Peptides Average Price (US$/Mg) of Manufacturers (2021-2026) Table 11. Global Antimicrobial Peptides Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antimicrobial Peptides, Product Type & Application Table 14. Global Antimicrobial Peptides Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antimicrobial Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AnaSpec Company Information Table 19. AnaSpec Business Overview Table 20. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 21. AnaSpec Antimicrobial Peptides Product Portfolio Table 22. AnaSpec Recent Developments Table 23. AMP Biotech Company Information Table 24. AMP Biotech Business Overview Table 25. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 26. AMP Biotech Antimicrobial Peptides Product Portfolio Table 27. AMP Biotech Recent Developments Table 28. Phoenix Biotech Company Information Table 29. Phoenix Biotech Business Overview Table 30. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 31. Phoenix Biotech Antimicrobial Peptides Product Portfolio Table 32. Phoenix Biotech Recent Developments Table 33. Novabiotics Company Information Table 34. Novabiotics Business Overview Table 35. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 36. Novabiotics Antimicrobial Peptides Product Portfolio Table 37. Novabiotics Recent Developments Table 38. Chinese Peptide Company Information Table 39. Chinese Peptide Business Overview Table 40. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 41. Chinese Peptide Antimicrobial Peptides Product Portfolio Table 42. Chinese Peptide Recent Developments Table 43. Ontores Company Information Table 44. Ontores Business Overview Table 45. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 46. Ontores Antimicrobial Peptides Product Portfolio Table 47. Ontores Recent Developments Table 48. GenScript Company Information Table 49. GenScript Business Overview Table 50. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 51. GenScript Antimicrobial Peptides Product Portfolio Table 52. GenScript Recent Developments Table 53. Hycult Biotech Company Information Table 54. Hycult Biotech Business Overview Table 55. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 56. Hycult Biotech Antimicrobial Peptides Product Portfolio Table 57. Hycult Biotech Recent Developments Table 58. Sunsmile Company Information Table 59. Sunsmile Business Overview Table 60. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 61. Sunsmile Antimicrobial Peptides Product Portfolio Table 62. Sunsmile Recent Developments Table 63. Ruixing Biotechnology Company Information Table 64. Ruixing Biotechnology Business Overview Table 65. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 66. Ruixing Biotechnology Antimicrobial Peptides Product Portfolio Table 67. Ruixing Biotechnology Recent Developments Table 68. Zhongnong Yingtai Biotechnology Company Information Table 69. Zhongnong Yingtai Biotechnology Business Overview Table 70. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 71. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio Table 72. Zhongnong Yingtai Biotechnology Recent Developments Table 73. Glam Technology Company Information Table 74. Glam Technology Business Overview Table 75. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 76. Glam Technology Antimicrobial Peptides Product Portfolio Table 77. Glam Technology Recent Developments Table 78. ProteLight Pharmaceutical & Biotechnology Company Information Table 79. ProteLight Pharmaceutical & Biotechnology Business Overview Table 80. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 81. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio Table 82. ProteLight Pharmaceutical & Biotechnology Recent Developments Table 83. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Antimicrobial Peptides Sales by Region (2021-2026) & (Mg) Table 85. Global Antimicrobial Peptides Sales Market Share by Region (2021-2026) Table 86. Global Antimicrobial Peptides Sales by Region (2027-2032) & (Mg) Table 87. Global Antimicrobial Peptides Sales Market Share by Region (2027-2032) Table 88. Global Antimicrobial Peptides Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Antimicrobial Peptides Revenue Market Share by Region (2021-2026) Table 90. Global Antimicrobial Peptides Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Antimicrobial Peptides Revenue Market Share by Region (2027-2032) Table 92. North America Antimicrobial Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 94. North America Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 95. North America Antimicrobial Peptides Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Antimicrobial Peptides Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Antimicrobial Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 99. Europe Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 100. Europe Antimicrobial Peptides Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Antimicrobial Peptides Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Antimicrobial Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 104. Asia Pacific Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 105. Asia Pacific Antimicrobial Peptides Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Antimicrobial Peptides Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Antimicrobial Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 109. South America Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 110. South America Antimicrobial Peptides Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Antimicrobial Peptides Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Antimicrobial Peptides Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 114. Middle East and Africa Antimicrobial Peptides Sales by Country (2027-2032) & (Mg) Table 115. Middle East and Africa Antimicrobial Peptides Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Antimicrobial Peptides Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 118. Global Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 119. Global Antimicrobial Peptides Sales Market Share by Type (2021-2026) Table 120. Global Antimicrobial Peptides Sales Market Share by Type (2027-2032) Table 121. Global Antimicrobial Peptides Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Antimicrobial Peptides Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Antimicrobial Peptides Revenue Market Share by Type (2021-2026) Table 124. Global Antimicrobial Peptides Revenue Market Share by Type (2027-2032) Table 125. Global Antimicrobial Peptides Price by Type (2021-2026) & (US$/Mg) Table 126. Global Antimicrobial Peptides Price by Type (2027-2032) & (US$/Mg) Table 127. Global Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 128. Global Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 129. Global Antimicrobial Peptides Sales Market Share by Application (2021-2026) Table 130. Global Antimicrobial Peptides Sales Market Share by Application (2027-2032) Table 131. Global Antimicrobial Peptides Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Antimicrobial Peptides Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Antimicrobial Peptides Revenue Market Share by Application (2021-2026) Table 134. Global Antimicrobial Peptides Revenue Market Share by Application (2027-2032) Table 135. Global Antimicrobial Peptides Price by Application (2021-2026) & (US$/Mg) Table 136. Global Antimicrobial Peptides Price by Application (2027-2032) & (US$/Mg) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Antimicrobial Peptides Distributors List Table 140. Antimicrobial Peptides Customers List Table 141. Antimicrobial Peptides Industry Trends Table 142. Antimicrobial Peptides Industry Drivers Table 143. Antimicrobial Peptides Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antimicrobial Peptides Product Image Figure 5. Global Antimicrobial Peptides Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antimicrobial Peptides Market Size (2021-2032) & (US$ Million) Figure 7. Global Antimicrobial Peptides Sales (2021-2032) & (Mg) Figure 8. Global Antimicrobial Peptides Average Price (US$/Mg) & (2021-2032) Figure 9. Plant Antimicrobial Peptides Product Image Figure 10. Microbial Antimicrobial Peptides Product Image Figure 11. Animal Antimicrobial Peptides Product Image Figure 12. Pharmaceuticals Product Image Figure 13. Feed Additives Product Image Figure 14. Others Product Image Figure 15. Global Antimicrobial Peptides Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Antimicrobial Peptides Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Antimicrobial Peptides Sales by Region in 2025 Figure 21. Global Antimicrobial Peptides Revenue by Region in 2025 Figure 22. North America Antimicrobial Peptides Market Size by Country in 2025 Figure 23. North America Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 24. North America Antimicrobial Peptides Revenue Market Share by Country (2021-2032) Figure 25. United States Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Antimicrobial Peptides Market Size by Country in 2025 Figure 29. Europe Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 30. Europe Antimicrobial Peptides Revenue Market Share by Country (2021-2032) Figure 31. Germany Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Antimicrobial Peptides Market Size by Country in 2025 Figure 42. Asia Pacific Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Antimicrobial Peptides Revenue Market Share by Country (2021-2032) Figure 44. China Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Antimicrobial Peptides Market Size by Country in 2025 Figure 53. South America Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 54. South America Antimicrobial Peptides Revenue Market Share by Country (2021-2032) Figure 55. Brazil Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Antimicrobial Peptides Market Size by Country in 2025 Figure 59. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Country (2021-2032) Figure 61. Egypt Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Antimicrobial Peptides Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Antimicrobial Peptides Sales Market Share by Type (2021-2032) Figure 67. Global Antimicrobial Peptides Revenue Market Share by Type (2021-2032) Figure 68. Global Antimicrobial Peptides Price (US$/Mg) by Type (2021-2032) Figure 69. Global Antimicrobial Peptides Sales Market Share by Application (2021-2032) Figure 70. Global Antimicrobial Peptides Revenue Market Share by Application (2021-2032) Figure 71. Global Antimicrobial Peptides Price (US$/Mg) by Application (2021-2032) Figure 72. Antimicrobial Peptides Value Chain Figure 73. Antimicrobial Peptides Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Antimicrobial Peptides Industry Opportunities and Challenges

Scope & coverage.

Types
  • Plant Antimicrobial Peptides
  • Microbial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
Applications
  • Pharmaceuticals
  • Feed Additives
  • Others
Companies covered
  • AnaSpec
  • AMP Biotech
  • Phoenix Biotech
  • Novabiotics
  • Chinese Peptide
  • Ontores
  • GenScript
  • Hycult Biotech
  • Sunsmile
  • Ruixing Biotechnology
  • Zhongnong Yingtai Biotechnology
  • Glam Technology
  • ProteLight Pharmaceutical & Biotechnology

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antimicrobial Peptides Market Size (2021-2032)
  4. 2.2.2 Global Antimicrobial Peptides Sales (2021-2032)
  5. 2.2.3 Global Antimicrobial Peptides Market Average Price (2021-2032)
  6. 2.3 Antimicrobial Peptides by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Plant Antimicrobial Peptides
  9. 2.3.3 Microbial Antimicrobial Peptides
  10. 2.3.4 Animal Antimicrobial Peptides
  11. 2.4 Antimicrobial Peptides by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Pharmaceuticals
  14. 2.4.3 Feed Additives
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antimicrobial Peptides Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antimicrobial Peptides Sales (Mg) of Manufacturers (2021-2026)
  3. 3.3 Global Antimicrobial Peptides Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antimicrobial Peptides Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antimicrobial Peptides Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antimicrobial Peptides, Product Type & Application
  8. 3.8 Global Manufacturers of Antimicrobial Peptides, Established Date
  9. 3.9 Global Antimicrobial Peptides Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AnaSpec
  2. 4.1.1 AnaSpec Company Information
  3. 4.1.2 AnaSpec Business Overview
  4. 4.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
  6. 4.1.5 AnaSpec Recent Developments
  7. 4.2 AMP Biotech
  8. 4.2.1 AMP Biotech Company Information
  9. 4.2.2 AMP Biotech Business Overview
  10. 4.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
  12. 4.2.5 AMP Biotech Recent Developments
  13. 4.3 Phoenix Biotech
  14. 4.3.1 Phoenix Biotech Company Information
  15. 4.3.2 Phoenix Biotech Business Overview
  16. 4.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
  18. 4.3.5 Phoenix Biotech Recent Developments
  19. 4.4 Novabiotics
  20. 4.4.1 Novabiotics Company Information
  21. 4.4.2 Novabiotics Business Overview
  22. 4.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
  24. 4.4.5 Novabiotics Recent Developments
  25. 4.5 Chinese Peptide
  26. 4.5.1 Chinese Peptide Company Information
  27. 4.5.2 Chinese Peptide Business Overview
  28. 4.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
  30. 4.5.5 Chinese Peptide Recent Developments
  31. 4.6 Ontores
  32. 4.6.1 Ontores Company Information
  33. 4.6.2 Ontores Business Overview
  34. 4.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ontores Antimicrobial Peptides Product Portfolio
  36. 4.6.5 Ontores Recent Developments
  37. 4.7 GenScript
  38. 4.7.1 GenScript Company Information
  39. 4.7.2 GenScript Business Overview
  40. 4.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GenScript Antimicrobial Peptides Product Portfolio
  42. 4.7.5 GenScript Recent Developments
  43. 4.8 Hycult Biotech
  44. 4.8.1 Hycult Biotech Company Information
  45. 4.8.2 Hycult Biotech Business Overview
  46. 4.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
  48. 4.8.5 Hycult Biotech Recent Developments
  49. 4.9 Sunsmile
  50. 4.9.1 Sunsmile Company Information
  51. 4.9.2 Sunsmile Business Overview
  52. 4.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
  54. 4.9.5 Sunsmile Recent Developments
  55. 4.10 Ruixing Biotechnology
  56. 4.10.1 Ruixing Biotechnology Company Information
  57. 4.10.2 Ruixing Biotechnology Business Overview
  58. 4.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
  60. 4.10.5 Ruixing Biotechnology Recent Developments
  61. 4.11 Zhongnong Yingtai Biotechnology
  62. 4.11.1 Zhongnong Yingtai Biotechnology Company Information
  63. 4.11.2 Zhongnong Yingtai Biotechnology Business Overview
  64. 4.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
  66. 4.11.5 Zhongnong Yingtai Biotechnology Recent Developments
  67. 4.12 Glam Technology
  68. 4.12.1 Glam Technology Company Information
  69. 4.12.2 Glam Technology Business Overview
  70. 4.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
  72. 4.12.5 Glam Technology Recent Developments
  73. 4.13 ProteLight Pharmaceutical & Biotechnology
  74. 4.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
  75. 4.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
  76. 4.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
  78. 4.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments
5 Global Antimicrobial Peptides Market Scenario by Region
  1. 5.1 Global Antimicrobial Peptides Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antimicrobial Peptides Sales by Region: 2021-2032
  3. 5.2.1 Global Antimicrobial Peptides Sales by Region: 2021-2026
  4. 5.2.2 Global Antimicrobial Peptides Sales by Region: 2027-2032
  5. 5.3 Global Antimicrobial Peptides Revenue by Region: 2021-2032
  6. 5.3.1 Global Antimicrobial Peptides Revenue by Region: 2021-2026
  7. 5.3.2 Global Antimicrobial Peptides Revenue by Region: 2027-2032
  8. 5.4 North America Antimicrobial Peptides Market Facts & Figures by Country
  9. 5.4.1 North America Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antimicrobial Peptides Sales by Country (2021-2032)
  11. 5.4.3 North America Antimicrobial Peptides Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Antimicrobial Peptides Market Facts & Figures by Country
  16. 5.5.1 Europe Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Antimicrobial Peptides Sales by Country (2021-2032)
  18. 5.5.3 Europe Antimicrobial Peptides Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Antimicrobial Peptides Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Antimicrobial Peptides Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Antimicrobial Peptides Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Antimicrobial Peptides Market Facts & Figures by Country
  41. 5.7.1 South America Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Antimicrobial Peptides Sales by Country (2021-2032)
  43. 5.7.3 South America Antimicrobial Peptides Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Antimicrobial Peptides Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Antimicrobial Peptides Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Antimicrobial Peptides Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Antimicrobial Peptides Sales by Type (2021-2032)
  2. 6.1.1 Global Antimicrobial Peptides Sales by Type (2021-2032) & (Mg)
  3. 6.1.2 Global Antimicrobial Peptides Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antimicrobial Peptides Revenue by Type (2021-2032)
  5. 6.2.1 Global Antimicrobial Peptides Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antimicrobial Peptides Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antimicrobial Peptides Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antimicrobial Peptides Sales by Application (2021-2032)
  2. 7.1.1 Global Antimicrobial Peptides Sales by Application (2021-2032) & (Mg)
  3. 7.1.2 Global Antimicrobial Peptides Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antimicrobial Peptides Revenue by Application (2021-2032)
  5. 7.2.1 Global Antimicrobial Peptides Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antimicrobial Peptides Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antimicrobial Peptides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antimicrobial Peptides Value Chain Analysis
  2. 8.1.1 Antimicrobial Peptides Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antimicrobial Peptides Production Mode & Process
  5. 8.2 Antimicrobial Peptides Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antimicrobial Peptides Distributors
  8. 8.2.3 Antimicrobial Peptides Customers
9 Global Antimicrobial Peptides Analyzing Market Dynamics
  1. 9.1 Antimicrobial Peptides Industry Trends
  2. 9.2 Antimicrobial Peptides Industry Drivers
  3. 9.3 Antimicrobial Peptides Industry Opportunities and Challenges
  4. 9.4 Antimicrobial Peptides Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst